Lysophosphatidic acid receptor 4 signaling potentially modulates malignant behavior in human head and neck squamous cell carcinoma cells
Authors:
Open Access
- 5 March 2013
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 42 (5) , 1560-1568
Abstract
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common non-skin cancer worldwide. Despite improvement in therapeutic strategies, the prognosis of advanced HNSCC remains poor. The extacellular lipid mediators known as lysophosphatidic acids (LPAs) have been implicated in tumorigenesis of HNSCC. LPAs activate G-protein-coupled receptors not only in the endothelial differentiation gene (Edg) family (LPA1, LPA2, LPA3) but also in the phylogenetically distant non-Edg family (LPA4, LPA5, LPA6). The distinct roles of these receptor isoforms in HNSCC tumorigenesis have not been clarified. In the present study, we investigated the effect of ectopic expression of LPA4 in SQ-20B, an HNSCC cell line, expressing a trivial level of endogenous LPA4. LPA (18:1) stimulated proliferation of SQ-20B cells, but did not affect proliferation of HEp-2, an SCC cell line expressing higher levels of LPA4, comparable to those of with LPA1. LPA-stimulated proliferation of SQ-20B cells was attenuated by Ki16425 and Rac1 inhibitor, but not by Y-27632. Infection with doxycycline-regulatable adenovirus vector expressing green fluorescent protein-tagged LPA4 (AdvLPA4G) abolished LPA-stimulated proliferation in SQ-20B cells with the accumulation of G2/M-phasic cells. Ectopic LPA4 induction further downregulated proliferation of Ki16425-treated SQ-20B cells, of which downregulation was partially recovered by LPA. Ectopic LPA4 induction also downregulated proliferation of Rac1 inhibitor-treated SQ-20B cells, however, LPA no longer recovered it. Finally, LPA-induced cell motility was suppressed by ectopic LPA4 expression as well as by Ki16425, Rac1 inhibitor or Y-27632. Our data suggest that LPA4 signaling potentially modulates malignant behavior of SQ-20B cells. LPA signaling, which is mediated by both Edg and non-Edg receptors, may be a determinant of malignant behavior of HNSCC and could therefore be a promising therapeutic target.Keywords
This publication has 43 references indexed in Scilit:
- Rho protein crosstalk: another social network?Trends in Cell Biology, 2011
- Effects of Lysophospholipids on Tumor MicroenvironmentCancer Microenvironment, 2011
- The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migrationMolecular Biology of the Cell, 2011
- The Mutational Landscape of Head and Neck Squamous Cell CarcinomaScience, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Identification and Characterization of a Novel Lysophosphatidic Acid Receptor, p2y5/LPA6Journal of Biological Chemistry, 2009
- Dysregulated molecular networks in head and neck carcinogenesisOral Oncology, 2009
- Role of LPA4/p2y9/GPR23 in Negative Regulation of Cell MotilityMolecular Biology of the Cell, 2008
- Farnesyl phosphates are endogenous ligands of lysophosphatidic acid receptors: Inhibition of LPA GPCR and activation of PPARsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006
- The emerging role of lysophosphatidic acid in cancerNature Reviews Cancer, 2003